HMGCR and isolated hemihyperplasia: We surmised that if the MVP is critical to IH onset and progression, statins — competitive inhibitors of the rate-limiting enzyme in the MVP, HMGCR — would inhibit HemSC blood vessel formation in a preclinical IH model.